BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Syneos Health, Inc. (SYNH) and Encourages SYNH Investors to Contact the Firm
March 01, 2019 19:36 ET | Bragar Eagel & Squire
NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Stamps.com Inc. (STMP) and Encourages STMP Investors to Contact the Firm
March 01, 2019 19:07 ET | Bragar Eagel & Squire
NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating EverQuote, Inc. (EVER) on Behalf of Stockholders and Encourages EVER Investors to Contact the Firm
February 26, 2019 20:22 ET | Bragar Eagel & Squire
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against EverQuote, Inc. (NASDAQ: EVER).  Our investigation concerns whether EverQuote...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AVEO Pharmaceuticals, Inc. (AVEO) and Encourages AVEO Investors to Contact the Firm
February 26, 2019 20:18 ET | Bragar Eagel & Squire
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Conagra Brands, Inc. (CAG) and Encourages CAG Investors to Contact the Firm
February 26, 2019 20:00 ET | Bragar Eagel & Squire
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Activision Blizzard, Inc. (ATVI) and Encourages ATVI Investors to Contact the Firm
February 26, 2019 15:25 ET | Bragar Eagel & Squire
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against The Kraft Heinz Company (KHC) and Encourages KHC Investors to Contact the Firm
February 25, 2019 20:21 ET | Bragar Eagel & Squire
NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating Stamps.com Inc. (STMP) on Behalf of Stockholders and Encourages STMP Investors to Contact the Firm
February 24, 2019 18:54 ET | Bragar Eagel & Squire
NEW YORK, Feb. 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Stamps.com Inc. (NASDAQ: STMP).  Our investigation concerns whether Stamps.com’s...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AxoGen, Markel, Maxar, and Wirecard and Encourages Investors to Contact the Firm
February 24, 2019 18:08 ET | Bragar Eagel & Squire
NEW YORK, Feb. 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of AxoGen, Inc., Markel...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating Diplomat Pharmacy, Inc. (DPLO) on Behalf of Stockholders and Encourages DPLO Investors to Contact the Firm
February 22, 2019 18:23 ET | Bragar Eagel & Squire
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Diplomat Pharmacy, Inc. (NYSE: DPLO).  Our investigation concerns whether...